About the Authors
- Noa Madar-Balakirski
-
Affiliation Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel
- Catherine Tempel-Brami
-
Affiliation Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel
- Vyacheslav Kalchenko
-
Affiliation Department of Veterinary Resources, The Weizmann Institute of Science, Rehovot, Israel
- Ori Brenner
-
Affiliation Department of Veterinary Resources, The Weizmann Institute of Science, Rehovot, Israel
- David Varon
-
Affiliation Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
- Avigdor Scherz
-
Contributed equally to this work with: Avigdor Scherz, Yoram Salomon
Affiliation Department of Plant Sciences, The Weizmann Institute of Science, Rehovot, Israel
- Yoram Salomon
-
Contributed equally to this work with: Avigdor Scherz, Yoram Salomon
* E-mail: yoram.salomon@weizmann.ac.il
Affiliation Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel
Competing Interests
Y.S. and A.S. are the inventors of Tookad; patent owned by the Weizmann Institute of Science, Rehovot, Israel, licensed to STEBA biotech, France (Scherz A, Salomon Y, Scheer H, Brandis A (2003) Palladium-substituted bacteriochlorophyll derivatives and use thereof, US patent 6569846, reference #20 in the manuscript). A.S. and Y.S. serve as consultants to STEBA biotech. This does not alter adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: NMB AS YS. Performed the experiments: NMB CTB VK. Analyzed the data: NMB CTB VK OB AS YS. Wrote the paper: NMB DV AS YS.